ID: ALA5271395

Max Phase: Preclinical

Molecular Formula: C30H44Br2N10O4

Molecular Weight: 768.56

Associated Items:

Representations

Canonical SMILES:  COc1c(Br)cc(C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc2ccccc2)cc1Br

Standard InChI:  InChI=1S/C30H44Br2N10O4/c1-46-25-20(31)15-19(16-21(25)32)17-24(42-26(43)22(33)9-5-12-39-29(34)35)28(45)41-23(10-6-13-40-30(36)37)27(44)38-14-11-18-7-3-2-4-8-18/h2-4,7-8,15-16,22-24H,5-6,9-14,17,33H2,1H3,(H,38,44)(H,41,45)(H,42,43)(H4,34,35,39)(H4,36,37,40)/t22-,23-,24-/m0/s1

Standard InChI Key:  QDBQJEIICWWEIN-HJOGWXRNSA-N

Associated Targets(non-human)

Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cyberlindnera jadinii (900 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aspergillus fumigatus (16427 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 768.56Molecular Weight (Monoisotopic): 766.1914AlogP: 0.95#Rotatable Bonds: 19
Polar Surface Area: 246.35Molecular Species: BASEHBA: 7HBD: 10
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 13#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.58CX Basic pKa: 12.06CX LogP: 0.39CX LogD: -4.35
Aromatic Rings: 2Heavy Atoms: 46QED Weighted: 0.06Np Likeness Score: 0.17

References

1. Craig AJ, Ermolovich Y, Cameron A, Rodler A, Wang H, Hawkes JA, Hubert M, Björkling F, Molchanova N, Brimble MA, Moodie LWK, Svenson J..  (2023)  Antimicrobial Peptides Incorporating Halogenated Marine-Derived Amino Acid Substituents.,  14  (6): [PMID:37312845] [10.1021/acsmedchemlett.3c00093]

Source